Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Oct 14, 2009; 15(38): 4829-4832
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4829
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4829
Table 2 Results (mean ± SD)
| Variable | Butorphanol group | Meperidine group | P value |
| Operative time (min) | 46.17 ± 15.59 | 48.43 ± 10.80 | 0.515 |
| Frequent of analgesia (times) | 3.03 ± 1.67 | 1.23 ± 0.504 | < 0.001 |
| VAS (6 h after surgery) | 5.67 ± 0.88 | 5.77 ± 1.00 | 0.684 |
| VAS (before analgesia) | 8.17 ± 1.66 | 8.31 ± 1.36 | 0.719 |
| VAS (after analgesia) | 5.93 ± 1.41 | 5.52 ± 1.12 | 0.216 |
| VAS (the next morning) | 6.13 ± 1.47 | 5.93 ± 1.14 | 0.560 |
| Hospital stay (d) | 3.63 ± 0.69 | 3.73 ± 0.74 | 0.585 |
- Citation: Mai CM, Wan LT, Chou YC, Yang HY, Wu CC, Jao SW, Hsiao CW. Efficacy and safety of transnasal butorphanol for pain relief after anal surgery. World J Gastroenterol 2009; 15(38): 4829-4832
- URL: https://www.wjgnet.com/1007-9327/full/v15/i38/4829.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.4829